WELLS FARGO & COMPANY/MN - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 51 filers reported holding RECRO PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$361
-56.2%
770
+2.7%
0.00%
Q2 2023$825
-77.8%
750
-76.0%
0.00%
Q1 2023$3,720
-15.3%
3,126
+6.0%
0.00%
Q4 2022$4,393
-12.1%
2,948
+0.3%
0.00%
Q3 2022$5,0002,939
+432.4%
0.00%
Q2 2022$0552
+17.7%
0.00%
Q1 2022$0469
+0.6%
0.00%
Q4 2021$0
-100.0%
466
+0.2%
0.00%
Q3 2021$1,0000.0%465
+2.0%
0.00%
Q2 2021$1,000
-98.2%
456
-97.7%
0.00%
Q1 2021$57,000
-6.6%
20,147
-4.8%
0.00%
Q4 2020$61,000
-31.5%
21,152
-50.2%
0.00%
Q3 2020$89,000
-75.1%
42,488
-45.9%
0.00%
Q2 2020$357,000
-79.6%
78,495
-63.3%
0.00%
-100.0%
Q1 2020$1,747,000
-8.5%
213,698
+105.1%
0.00%0.0%
Q4 2019$1,910,000
+216.7%
104,189
+91.6%
0.00%
Q3 2019$603,000
+14.6%
54,375
+5.1%
0.00%
Q2 2019$526,000
+114.7%
51,754
+23.7%
0.00%
Q1 2019$245,000
-74.7%
41,837
-69.4%
0.00%
Q4 2018$970,000
+0.3%
136,553
+0.4%
0.00%
Q3 2018$967,000
+10.0%
135,991
-22.3%
0.00%
Q2 2018$879,000
+3.9%
175,092
+127.9%
0.00%
Q1 2018$846,000
+73.0%
76,832
+45.4%
0.00%
Q4 2017$489,000
+122.3%
52,848
+115.6%
0.00%
Q3 2017$220,000
+81.8%
24,508
+42.5%
0.00%
Q2 2017$121,000
-19.3%
17,2000.0%0.00%
Q1 2017$150,000
+11.1%
17,200
+3.0%
0.00%
Q4 2016$135,000
-51.1%
16,700
-46.5%
0.00%
Q3 2016$276,000
+73.6%
31,200
+56.0%
0.00%
Q2 2016$159,00020,0000.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders